Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences

Brain Research

Volumn 1318, Issue , 2010, Pages 77-86

  Deo, Gajanan S ^a   Dandekar, Manoj P ^a   Upadhya, Manoj A ^a   Kokare, Dadasaheb M ^a   Subhedar, Nishikant K ^b  

^a RTM NAGPUR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Allopregnanolone; Anxiety; Central nucleus of amygdala; Immunocytochemistry; Neuropeptide Y; Vogel's conflict test

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; DIAZEPAM; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ANXIETY; ARCUATE NUCLEUS; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL TEST; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NERVE FIBER; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; STRIA TERMINALIS; TRANQUILIZING ACTIVITY;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ARCUATE NUCLEUS; ARGININE; CENTRAL NERVOUS SYSTEM AGENTS; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEUROPEPTIDE Y; NEUROPSYCHOLOGICAL TESTS; NUCLEUS ACCUMBENS; PREGNANOLONE; RECEPTORS, NEUROPEPTIDE Y; SEPTAL NUCLEI;

MUS;

EID: 76649084221     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.088     Document Type: Article

References (48)

1. Abelson J.L., Le Melledo J., and Bichet D.G. Dose response of argenine vasopressin to the CCK-B agonist pentagastrin. Neuropsychopharmacology 4 (2001) 161-169
2. Akwa Y., Purdy R.H., Koof G.F., and Britton K.T. The amygdala mediates anxiolytic-like effect of neurosteroid in the rat. Behav. Brain Res. 106 (1999) 119-125
3. Allen Y.S., Roberts G.W., Bloom S.R., Crow T.J., and Polak J.M. Neuropeptide Y in the stria terminalis: evidence for an amygdalofugal projection. Brain Res. 321 (1984) 357-362
4. Baker K.B., and Kim J.J. Amygdalar lateralization in fear conditioning: evidence for greater involvement of the right amygdala. Behav. Neurosci. 118 (2004) 15-23
5. Bicikova M., and Hampl R. Neurosteroids and their function. Cas. Lek. Ces. 146 (2007) 223-226
6. Birzniece V., Bäckström T., Johansson I.M., Lindblad C., Lundgren P., Löfgren M., Olsson T., Ragagnin G., Taube M., Turkmen S., Wahlström G., Wang M.D., Wihlbäck A.C., and Zhu D. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res. Rev. 51 (2006) 212-239
7. A receptors. Eur. J. Pharmacol. 325 (1997) 1-7
8. Chronwall B.M. Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 6 (1985) 1-11
9. Dandekar M.P., Singru P.S., Kokare D.M., Lechan R.M., Thim L., Clausen J.T., and Subhedar N.K. Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal. Neuropsychopharmacology 33 (2008) 1127-1136
10. Dandekar M.P., Singru P.S., Kokare D.M., and Subhedar N.K. Cocaine- and amphetamine-regulated transcript peptide (CART) plays a role in the manifestation of depression: social isolation and olfactory bulbectomy models reveal unifying principles. Neuropsychopharmacology 34 (2009) 1288-1300
11. A and the NPY-Y1 receptor mediated signals in the amygdala. Pharmacol. Biochem. Behav. 84 (2006) 568-580
12. Eva C., Serra M., Mele P., Panzica G., and Oberto A. Physiology and gene regulation of the brain NPY Y1 receptor. Front. Neuroendocrinol. 27 (2006) 308-539
13. Ferrara G., Serra M., Zammaretti F., Pisu M.G., Panzica G.C., Biggio G., and Eva C. Increased expression of the NPY Y1 receptor gene in the medial amygdala of transgenic mice induced by long term treatment with progesterone or allopregnanolone. J. Neurochem. 79 (2001) 417-425
14. Finn D.A., Snelling C., Fretwell A.M., Tanchuck M.A., Underwood L., Cole M., Crabbe J.C., and Roberts A.J. Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41). Alcohol. Clin. Exp. Res. 31 (2007) 939-949
15. Frye C.A., and Bayon L.E. Prenatal stress reduces the effectiveness of the neurosteroid 3-alpha,5-alpha THP to block Kainic acid induced seizure. Dev. Psychobiol. 34 (1999) 227-234
16. A receptors and neuropeptide secretion by the neurosteroid ALLO in posterior and intermediate pituitary. Pharmacol. Toxicol. 93 (2003) 91-97
17. Heilig M., Soderpalm B., Engel J.A., and Widerlov E. Centrally administered neuropeptide Y produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 98 (1989) 524-529
18. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., and Britton K.T. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8 (1993) 357-363
19. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., and Koob G.F. Evidence for greater involvement of the right amygdala. Behav. Neurosci. 118 (1994) 15-23
20. Kash T.L., and Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 51 (2006) 1013-1022
21. Kask A., Lembit R., and Jaanus H. Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226:antagonism with diazepam. Eur. J. Pharmacol. 317 (1996) 3-4
22. Kask A., Rägo L., and Harro J. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats. Neuroreport 10 (1997) 3645-3647
23. Kask A., Eller M., Oreland L., and Harro J. Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behavior in the rats. Neuropeptides 34 (2000) 58-61
24. Kask A., Harro J., von Hörsten S., Redrobe J.P., Dumont Y., and Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 26 (2002) 259-283
25. Khisti R.T., Chopde C.T., and Jain S.P. Antidepressant-like effect of 3α-hydroxy-5α-pregnan-20-one in mice forced swim test. Pharmacol. Biochem. Behav. 67 (2000) 137-143
26. Kokare D.M., Dandekar M.P., Chopde C.T., and Subhedar N. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Res. 1043 (2005) 107-114
27. Kokare D.M., Chopde C.T., and Subhedar N.K. Participation of α-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats. Neuropharmacology 51 (2006) 536-545
28. Lancel M., Feulhaber J., Schiffelholz T., Romeo E., di Michele F., Ruppercht R., and Holsboer F. ALLO affects sleep in a benzodiazepine fashion. J. Pharmacol. Exp. Ther. 282 (1997) 1213-1218
29. LeDoux J. Fear and the brain: where have we been, and where are we going?. Biol. Psychiatry 15 (1998) 1229-1238
30. Lonsdale D., and Burnham W.M. The anticonvulsant effects of allopregnanolone against amygdala-kindled seizures in female rats. Neurosci. Lett. 10 (2007) 147-151
31. Mele P., Oberto A., Serra M., Pisu M.G., Flori I., Biggio G., and Eva C. Increased expression of the gene for the Y1 receptor of neuropeptide Y in the amygdala and the paraventricular nucleus of Y1R/LacZ transgenic mice in response to restraint stress. J. Neurochem. 89 (2004) 1471-1478
32. Moller C.M., Sommer W., Thorsell A., and Heiliq M. Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology 21 (1999) 507-512
33. Nakhate K.T., Dandekar M.P., Kokare D.M., and Subhedar N.K. Involvement of neuropeptide Y Y1 receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats. Eur. J. Pharmacol. 609 (2009) 78-87
34. Oberto A., Serra M., Pisu M.G., Biggio G., and Eva C. Changes in expression of neuropeptide Y Y1 receptor gene in the medial amygdala of transgenic mice during pregnancy and after delivery. J. Neurochem. 82 (2002) 1272-1281
35. Pandey S.C., Roy A., and Zhang H. The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Alcohol. Clin. Exp. Res. 27 (2003) 396-409
36. Paxinos G., and Franklin K.B. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, California
37. A receptor agonist muscimol. Neuropharmacology 39 (2000) 440-448
38. Primeaux S.D., Wilson S.P., Cusick M.C., York D.A., and Wilson M.A. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 30 (2005) 1589-1597
39. Sajdyk T.J., Vandergriff M.G., and Gehlert D.R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 368 (1999) 143-147
40. Sajdyk T.J., Schober D.A., and Gehlert D.R. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 43 (2002) 1165-1172
41. Sanders S.K., Morzorati S.L., and Shekhar A. Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala. Brain Res. 20 (1995) 250-259
42. A receptor function in rat brain. J. Neurochem. 75 (2000) 732-740
43. A receptors triggers anxiety at puberty. Nat. Neurosci. 10 (2007) 397-399
44. Ugale R.R., Sharma A.N., Kokare D.M., Hirani K., Subhedar N.K., and Chopde C.T. Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats. Brain Res. 1184 (2007) 193-201
45. Upadhya M.A., Dandekar M.P., Kokare D.M., Singru P.S., and Subhedar N.K. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates. Neuropeptides 43 (2009) 303-314
46. Vogel J.R., Beer B., and Clody D.E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21 (1971) 1-7
47. Walker D.L., and Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J. Neurosci. 17 (1997) 9375-9383
48. Wehrenberg W.B., Corder R., and Gaillard R.C. A physiological role of neuropeptide Y in regulating the estrogen/progesterone induced luteinizing hormone surge in ovariectomized rats. Neuroendocrinology 49 (1989) 680-682